Supplier · Large organisation

Novartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd has won 18 UK public contracts worth £1.26bn since 16 Dec 2020. See its competitors in medical equipment & pharmaceuticals.

Company 00119006Companies House record Based in LondonFirst contract 16 Dec 2020Latest contract 5 Jan 2026

Contracts: 18
Published value: £1.26bnwhere stated
Without competition: 0%0 contracts
Won by SMEs: 6%of 17 with size known

Contracts won per month, last 24 months 5 contracts · busiest month March 2025

Dec 24
2Mar 25
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26

Biggest customers

NHS England 6 contracts · £1.24bn
The NHS Commissioning Board (operating under the name of NHS England) 5 contracts · £5
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") 3 contracts · £3.65m
eTenderwales 1 contract · £8.73m
Regional Business Services Organisation Procurement and Logistics Service 1 contract · £1.64m
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") 1 contract · £282k
Procurement and Logistics Service 1 contract · £131k

What they supply

Medical equipment & pharmaceuticals 18 contracts · £1.26bn

Competitors in medical equipment & pharmaceuticals

Sector overview

Medtronic Limited 156 contracts · £6.73bn
NHS Supply Chain Coordination Limited (NHSSC - SCCL) 117 contracts · £20.2m
B. Braun Medical Limited 107 contracts · £5.7bn
Johnson & Johnson Medical Limited 94 contracts · £3.38bn
Stryker UK Limited 70 contracts · £2.09bn
Boston Scientific Limited 67 contracts · £3.36bn

These are the suppliers with the most medical equipment & pharmaceuticals contracts in the last two years, which is where Novartis Pharmaceuticals UK Ltd wins most of its work. They are not necessarily bidding for the same contracts. See the whole sector.

All contracts won by Novartis Pharmaceuticals UK Ltd

Contracts won by Novartis Pharmaceuticals UK Ltd
Date	Contract	Buyer	Value
5 Jan 2026	Generic, Branded Generic & Proprietary Medicinal Products - Group 17	Regional Business Services Organisation Procurement and Logistics Service	£1.64m
25 Jul 2025	NP30925 Psychiatry and Neurology Medicines: Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	£282k
17 Jun 2025	Proprietary Drugs	eTenderwales	£8.73m
24 Mar 2025	NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025	NHS England	£1
24 Mar 2025	NHS Framework Agreement for Branded Medicines - Proprietary Category Tender	NHS England	£1.24bn
22 Jul 2024	NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/03 - Omalizumab and Diroximel Fumarate for MAE & NOFE - Lot 3	NHS England	£1
22 Jul 2024	NHS Branded Medicines Tranche Framework for London and South of England: CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1	NHS England	£1
2 Jul 2024	Generic, Branded Generic & Proprietary Medicinal Products - Group 14	Procurement and Logistics Service	£131k
14 Jul 2023	NHS London Branded Medicines - Tranche B - September 2023: CM/PHR/22/5677/01 - NHS London Branded Medicines - Tranche B Lot 1	NHS England	£1
14 Jul 2023	NHS London Branded Medicines - Tranche B - September 2023: CM/PHR/22/5677/02 - NHS London Branded Medicines - Tranche B Lot 2	NHS England	£1
10 Feb 2021	NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche: Lot 2: North of England (NOFE) Annual Tranche	The NHS Commissioning Board (operating under the name of NHS England)	£1
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	£1
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.: Lot 2: Midlands and East Cytokine Modulators and other monoclonal antibodies	The NHS Commissioning Board (operating under the name of NHS England)	£1
25 Jan 2021	NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	£1
15 Jan 2021	NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib	The NHS Commissioning Board (operating under the name of NHS England)	£1
16 Dec 2020	Oncology Generics Medicines: Lot 30 Octreotide Vials Long Acting (Excluding Homecare)	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£3.26m
16 Dec 2020	Oncology Generics Medicines: Lot 31 Octreotide Vials Long Acting (Including Homecare)	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£50,148
16 Dec 2020	Oncology Generics Medicines: Lot 11 Imatinib	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	£341k

Contracts are matched to this supplier by company name as published in each notice. If a company appears under slightly different names, some of its contracts may be listed separately. How matching works.